receiver operating characteristic-curve analyses of randomly selected patients (33%; N = 82) of various glioma grades and brain metastasis, showed a high accuracy area under the curve of 90% for the percentage CD16+GFAP+ monocytes predicting for a brain lesion. This evidence concerns the gene GFAP and central nervous system cancer.